Top 3 Undervalued Small Caps With Insider Buys To Watch In September 2024

As global markets navigate mixed signals from key economic indicators and light trading volumes ahead of the holiday weekend, value stocks have notably outperformed growth shares. This dynamic creates an intriguing backdrop for small-cap investors, particularly those looking for undervalued opportunities with insider buying activity. In such a market environment, identifying small-cap stocks that exhibit strong fundamentals and insider confidence can be particularly rewarding. Here are three undervalued small caps with recent insider buys to watch in September 2024.

Top 10 Undervalued Small Caps With Insider Buying

Name	PE	PS	Discount to Fair Value	Value Rating
Bytes Technology Group	23.7x	5.4x	16.08%	★★★★★☆
Trican Well Service	7.9x	1.0x	10.60%	★★★★★☆
Essentra	812.3x	1.6x	47.50%	★★★★★☆
Cabka	NA	0.4x	49.63%	★★★★★☆
Thryv Holdings	NA	0.7x	24.15%	★★★★★☆
Franklin Financial Services	10.3x	2.0x	35.85%	★★★★☆☆
CVS Group	22.3x	1.2x	41.17%	★★★★☆☆
Community West Bancshares	18.7x	2.9x	42.25%	★★★☆☆☆
Alta Equipment Group	NA	0.1x	-74.08%	★★★☆☆☆
Industrial Logistics Properties Trust	NA	0.7x	-246.88%	★★★☆☆☆

Click here to see the full list of 197 stocks from our Undervalued Small Caps With Insider Buying screener.

Let's dive into some prime choices out of from the screener.

MaxLinear (NasdaqGS:MXL)

Simply Wall St Value Rating: ★★★★☆☆

Overview: MaxLinear is a company that designs and sells semiconductor products, with a market cap of approximately $3.24 billion.

Operations: MaxLinear generates revenue primarily from its semiconductor segment, which recently reported $448.14 million. The company's gross profit margin has shown variability, with the latest figure at 53.99%. Operating expenses are significant, driven by high R&D and general administrative costs.

PE: -6.0x

MaxLinear, a notable player in the data storage industry, has recently showcased its Panther III storage accelerator at various conferences. This product promises significant cost and energy savings by reducing CPU core requirements and enhancing storage capacity. Despite a challenging financial period with Q2 sales dropping to US$91.99 million from US$183.94 million the previous year, insider confidence remains high as Kishore Seendripu purchased 108,303 shares valued at approximately US$1.4 million in July 2024.

• Unlock comprehensive insights into our analysis of MaxLinear stock in this valuation report.

• Gain insights into MaxLinear's past trends and performance with our Past report.

Marksans Pharma (NSEI:MARKSANS)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Marksans Pharma is a pharmaceutical company engaged in the development, manufacture, and marketing of generic pharmaceutical formulations with a market cap of ₹7.34 billion.

Operations: Marksans Pharma generates revenue primarily from its pharmaceuticals segment, with significant operating expenses impacting its net income. The company's gross profit margin has shown variability, reaching up to 56.52% in recent periods.

PE: 35.5x

Marksans Pharma, a small pharmaceutical company, has shown promising growth with earnings forecasted to increase by 20.81% annually. Recent insider confidence is evident with significant share purchases in the past quarter. The USFDA successfully closed an inspection of their Goa facility in April 2024, boosting operational credibility. First-quarter results for FY25 reported sales at INR 5,906 million and net income at INR 888 million, reflecting solid financial performance and potential for future expansion through M&A activities in Europe.

• Click here and access our complete valuation analysis report to understand the dynamics of Marksans Pharma.

• Learn about Marksans Pharma's historical performance.

IGG (SEHK:799)

Simply Wall St Value Rating: ★★★★★☆

Overview: IGG is a company that focuses on the development and operation of online games, with a market cap of HK$4.68 billion.

Operations: The company generates revenue primarily from the development and operation of online games, with a recent gross profit margin of 77.58%. Significant costs include sales and marketing expenses, which were HK$2.37 billion, and R&D expenses amounting to HK$828.94 million in the latest period.

PE: 5.0x

IGG Inc., a small cap, reported H1 2024 sales of HK$2.74 billion, up from HK$2.50 billion in the same period last year. Net income swung to HK$330.95 million from a net loss of HK$359.8 million previously, indicating improved profitability. Basic earnings per share rose to HK$0.29 from a loss per share of HK$0.31 last year, with diluted EPS at similar levels. Insider confidence is evident with recent purchases by key executives over the past quarter, suggesting positive internal sentiment about future growth prospects.

• Get an in-depth perspective on IGG's performance by reading our valuation report here.

• Understand IGG's track record by examining our Past report.

Seize The Opportunity

• Gain an insight into the universe of 197 Undervalued Small Caps With Insider Buying by clicking here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com